跳至主要内容
临床试验/NCT00244205
NCT00244205Unknown不适用

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.

Copenhagen University Hospital at Herlev1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1

研究概览

简要总结

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.

排除标准

  • Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.

研究者

发起方
Copenhagen University Hospital at Herlev
申办方类型
Other

研究点 (1)

Loading locations...

相似试验